IL95158A0 - Pharmaceutical composition for oral administration containing n-acetyl-cysteine - Google Patents
Pharmaceutical composition for oral administration containing n-acetyl-cysteineInfo
- Publication number
- IL95158A0 IL95158A0 IL95158A IL9515890A IL95158A0 IL 95158 A0 IL95158 A0 IL 95158A0 IL 95158 A IL95158 A IL 95158A IL 9515890 A IL9515890 A IL 9515890A IL 95158 A0 IL95158 A0 IL 95158A0
- Authority
- IL
- Israel
- Prior art keywords
- cysteine
- acetyl
- pharmaceutical composition
- oral administration
- administration containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8921339A IT1231012B (it) | 1989-07-27 | 1989-07-27 | Composizione farmaceutica per uso orale contenente nac. |
Publications (1)
Publication Number | Publication Date |
---|---|
IL95158A0 true IL95158A0 (en) | 1991-06-10 |
Family
ID=11180335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL95158A IL95158A0 (en) | 1989-07-27 | 1990-07-23 | Pharmaceutical composition for oral administration containing n-acetyl-cysteine |
Country Status (20)
Country | Link |
---|---|
US (1) | US5080906A (da) |
JP (1) | JPH0399012A (da) |
KR (1) | KR910002438A (da) |
AU (1) | AU625925B2 (da) |
BE (1) | BE1003188A4 (da) |
CA (1) | CA2021808A1 (da) |
CH (1) | CH680190A5 (da) |
DE (1) | DE4023774A1 (da) |
DK (1) | DK177890A (da) |
FI (1) | FI903759A0 (da) |
FR (1) | FR2650503B1 (da) |
GB (1) | GB2234171B (da) |
GR (1) | GR900100569A (da) |
IE (1) | IE902627A1 (da) |
IL (1) | IL95158A0 (da) |
IT (1) | IT1231012B (da) |
NL (1) | NL9001714A (da) |
NZ (1) | NZ234647A (da) |
SE (1) | SE9002500L (da) |
ZA (1) | ZA905861B (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5580577A (en) * | 1990-01-11 | 1996-12-03 | Herzenberg; Leonard A. | Method of treating the symptoms of human rhinovirus infection |
US5286480A (en) * | 1992-06-29 | 1994-02-15 | The Procter & Gamble Company | Use of N-acetylated amino acid complexes in oral care compositions |
IT1256616B (it) * | 1992-12-02 | 1995-12-12 | Zambon Spa | Sciroppo contenente n-acetil-cisteina |
GB9226729D0 (en) * | 1992-12-22 | 1993-02-17 | Wellcome Found | Therapeutic combination |
US5637616A (en) * | 1993-06-18 | 1997-06-10 | Arcturus Pharmaceutical Corporation | Method for treating diseases mediated by proteases |
BE1007926A3 (fr) * | 1994-01-31 | 1995-11-21 | Zambon Int Pharma | Composition pharmaceutique contenant de la n-acetyl-cysteine. |
ATE448782T1 (de) | 1996-12-31 | 2009-12-15 | Antioxidant Pharmaceuticals Co | Pharmazeutische glutathionpräparate und methoden zu dern verabreichung |
US6896899B2 (en) * | 1996-12-31 | 2005-05-24 | Antioxidant Pharmaceuticals Corp. | Pharmaceutical preparations of glutathione and methods of administration thereof |
FR2803720B1 (fr) * | 2000-01-18 | 2004-10-22 | Roquette Freres | Lozenges a base de dextrose et leur procede de fabrication |
US6114387A (en) * | 2000-02-16 | 2000-09-05 | Cutler; Paul | Pharmaceutical composition for oral administration of chelating agents |
US6632459B2 (en) * | 2000-12-11 | 2003-10-14 | Nutricia N.V. | Chlorogenic acid and an analog thereof for immune system stimulation |
US20030162732A1 (en) * | 2001-07-05 | 2003-08-28 | Astion Development A/S | Combination of aminosugars and cysteine or cysteine derivatives |
US20090035260A1 (en) * | 2002-07-29 | 2009-02-05 | Therapicon Srl | Enhanced nasal composition of active peptide |
ITMI20021881A1 (it) * | 2002-09-04 | 2004-03-05 | Zambon Spa | Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario. |
US20050008699A1 (en) * | 2003-07-11 | 2005-01-13 | Fred Wehling | Effervescent glucosamine composition |
ITMI20040235A1 (it) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | Preparazione farmaceutica per il cavo orale |
KR20050104152A (ko) * | 2004-04-28 | 2005-11-02 | 최승호 | 경구용 약물의 흡수를 증진하는 약제학적 조성물 |
US20090197956A1 (en) * | 2008-02-04 | 2009-08-06 | Arbor Pharmaceuticals, Inc. | Treatment of acute otitis media with xylitol and n-acetylcysteine |
TR200900882A2 (tr) | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler. |
LT3554491T (lt) * | 2016-12-15 | 2023-05-25 | Zambon S.P.A. | N-acetilcisteinas, skirtas naudoti kaip antibakterinis agentas |
DK3829535T3 (da) * | 2018-07-27 | 2024-02-05 | Icf Srl | Sammensætninger til forebyggelse og behandling af kutane lidelser |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4081534A (en) * | 1973-09-11 | 1978-03-28 | Burroughs Wellcome Co. | Amino purine nucleosides as autoimmune suppressant agents |
US4877612A (en) * | 1985-05-20 | 1989-10-31 | Frank M. Berger | Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process |
CH667590A5 (it) * | 1986-07-24 | 1988-10-31 | Inpharzam Int Sa | Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. . |
US4894225A (en) * | 1987-03-02 | 1990-01-16 | Cetus Corporation | Combination therapy using antitumor immunotoxins with tumor necrosis factor |
JPS63290824A (ja) * | 1987-05-22 | 1988-11-28 | Sumitomo Chem Co Ltd | ウイルス感染症治療剤 |
IT1217445B (it) * | 1988-04-29 | 1990-03-22 | Altergon Sa | Composizione farmaceutiche orosolubili contenti acetilcisteina |
-
1989
- 1989-07-27 IT IT8921339A patent/IT1231012B/it active
-
1990
- 1990-07-18 IE IE262790A patent/IE902627A1/en unknown
- 1990-07-20 CH CH2424/90A patent/CH680190A5/it not_active IP Right Cessation
- 1990-07-23 IL IL95158A patent/IL95158A0/xx unknown
- 1990-07-24 CA CA002021808A patent/CA2021808A1/en not_active Abandoned
- 1990-07-25 JP JP2197575A patent/JPH0399012A/ja active Pending
- 1990-07-25 NZ NZ234647A patent/NZ234647A/en unknown
- 1990-07-25 GR GR900100569A patent/GR900100569A/el unknown
- 1990-07-25 FR FR909009493A patent/FR2650503B1/fr not_active Expired - Fee Related
- 1990-07-25 ZA ZA905861A patent/ZA905861B/xx unknown
- 1990-07-25 GB GB9016256A patent/GB2234171B/en not_active Expired - Fee Related
- 1990-07-26 BE BE9000746A patent/BE1003188A4/fr not_active IP Right Cessation
- 1990-07-26 SE SE9002500A patent/SE9002500L/xx not_active Application Discontinuation
- 1990-07-26 DE DE4023774A patent/DE4023774A1/de not_active Withdrawn
- 1990-07-26 DK DK177890A patent/DK177890A/da not_active Application Discontinuation
- 1990-07-27 FI FI903759A patent/FI903759A0/fi not_active Application Discontinuation
- 1990-07-27 NL NL9001714A patent/NL9001714A/nl not_active Application Discontinuation
- 1990-07-27 KR KR1019900011440A patent/KR910002438A/ko not_active Application Discontinuation
- 1990-07-27 US US07/558,672 patent/US5080906A/en not_active Expired - Fee Related
- 1990-07-27 AU AU59935/90A patent/AU625925B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU5993590A (en) | 1991-01-31 |
FI903759A0 (fi) | 1990-07-27 |
GB2234171B (en) | 1993-11-10 |
GB9016256D0 (en) | 1990-09-12 |
DE4023774A1 (de) | 1991-01-31 |
GR900100569A (el) | 1991-12-10 |
SE9002500D0 (sv) | 1990-07-26 |
DK177890A (da) | 1991-01-28 |
US5080906A (en) | 1992-01-14 |
IT8921339A0 (it) | 1989-07-27 |
CA2021808A1 (en) | 1991-01-28 |
JPH0399012A (ja) | 1991-04-24 |
FR2650503A1 (fr) | 1991-02-08 |
AU625925B2 (en) | 1992-07-16 |
CH680190A5 (da) | 1992-07-15 |
ZA905861B (en) | 1991-07-31 |
IE902627A1 (en) | 1991-02-27 |
NZ234647A (en) | 1992-02-25 |
FR2650503B1 (fr) | 1992-05-29 |
KR910002438A (ko) | 1991-02-25 |
DK177890D0 (da) | 1990-07-26 |
IT1231012B (it) | 1991-11-08 |
SE9002500L (sv) | 1991-01-28 |
BE1003188A4 (fr) | 1992-01-07 |
GB2234171A (en) | 1991-01-30 |
NL9001714A (nl) | 1991-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL82911A (en) | Pharmaceutical composition comprising omeprazole for oral use | |
IL95158A0 (en) | Pharmaceutical composition for oral administration containing n-acetyl-cysteine | |
EP0202051A3 (en) | Therapeutic compositions for oral administration | |
AU5157590A (en) | Pharmaceutical compositions for oral administration | |
IL83349A (en) | Stable pharmaceutical composition comprising cimetidine polymorph b suitable for oral administration | |
IL92054A0 (en) | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof,their preparation and pharmaceutical compositions containing them | |
ZA894344B (en) | Stable pharmaceutical composition | |
EP0448091A3 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
IL87943A0 (en) | Pharmaceutical compositions for piperidinoalkanol-decongestant combination | |
IL87921A0 (en) | Pharmaceutical composition for piperidinoalkanol derivatives | |
IL87494A0 (en) | Pharmaceutical compositions containing benzylpyrimidine derivatives | |
IL86437A0 (en) | Pharmaceutical compositions containing certain pyranoquinoline derivatives | |
ZA89552B (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones | |
GB8814615D0 (en) | 8-acrylaminoergoline its preparation & pharmaceutical compositions containing it | |
IL95105A0 (en) | Oral pharmaceutical compositions having controlled bioavailability | |
IL93270A0 (en) | Pharmaceutical compositions for oral administration | |
EG19689A (en) | New pharmaceutical preparation for oral use | |
AU647444B2 (en) | Oxipurinol salt composition for oral administration for treating hyperurecemia | |
IE900393L (en) | Pharmaceutical compositions for oral administration | |
IE861385L (en) | Oral pharmaceutical composition | |
AU601974C (en) | New pharmaceutical preparation for oral use | |
GB8605037D0 (en) | Oral pharmaceutical compositions | |
IE893646L (en) | Pharmaceutical compositions for topical administration | |
ZA887413B (en) | Pharmaceutical composition for piperidinoalkanol-decongestant combination | |
AU5273993A (en) | Oral pharmaceutical administration device |